LT

London Technology Fund

Europe, England, United Kingdom, London

Description

London Technology Fund is a venture capital firm that invests in technology-driven companies.

Investor Profile

London Technology Fund has made 6 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series Unknown (67%)
  • Series A (33%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Developer Tools
  • Product Design
  • Messaging
  • Network Security
  • Web Design
  • Life Science
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does London Technology Fund frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Truffle Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 2
TC
Europe, England, United Kingdom, London
Co-Investments: 1
Royal Society Enterprise Fund
Europe, England, United Kingdom, London
Co-Investments: 1
Laing O'Rourke
Europe, Kent, United Kingdom, Dartford
Co-Investments: 1
Imperial Innovations
Europe, England, United Kingdom, London
Co-Investments: 2
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 2

What are some of recent deals done by London Technology Fund?

Novacem

London, England, United Kingdom

Novacem is a UK-based developer of carbon negative cement.

Developer ToolsProduct Design
Series UnknownJan 27, 2011
Amount Raised: $2,389,962
Immune Targeting Systems

London, England, United Kingdom

Immune Targeting Systems develops synthetic vaccines for mutating viruses, improving the quality of life for those infected by viruses.

BiotechnologyHealth CareMedical
Series AMar 17, 2010
Amount Raised: $13,200,000
Novacem

London, England, United Kingdom

Novacem is a UK-based developer of carbon negative cement.

Developer ToolsProduct Design
Series UnknownAug 6, 2009
Amount Raised: $1,680,596
Immune Targeting Systems

London, England, United Kingdom

Immune Targeting Systems develops synthetic vaccines for mutating viruses, improving the quality of life for those infected by viruses.

BiotechnologyHealth CareMedical
Series AJul 16, 2007
Amount Raised: $7,129,820
ApplianSys

Coventry, Coventry, United Kingdom

ApplianSys is a UK-based server appliance specialist that designs, builds and markets a range of network appliances.

MessagingNetwork SecurityWeb Design
Series UnknownJan 18, 2007
Amount Raised: $802,697
deltaDOT

London, England, United Kingdom

A life science company that is developing and commercialising innovative technologies for the separation and analysis of biomolecules.

BiotechnologyLife ScienceManufacturing
Series UnknownMar 30, 2006
Amount Raised: $10,464,137